Showing results (141-150 of 1,902) with videos related to

Sort By:
Pageof 191
Therapeutic Drug Monitoring|February 2, 2023
Development of a Dose-Adjusted Polygenic Risk Model for Anthracycline-Induced CardiotoxicityAngela Siemens, Shahrad Rod Rassekh, Colin J D Ross, et al.
Annual Review of Pharmacology and Toxicology|October 2, 2020
Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical SettingsWan-Chun Chang, Reo Tanoshima, Colin J D Ross, et al.
Frontiers in Genetics|March 6, 2015
Use of pharmacogenomics in pediatric renal transplant recipientsMara Medeiros, Gilberto Castañeda-Hernández, Colin J D Ross, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|January 23, 1998
Biomechanical considerations of mandibular lengthening and widening by gradual distraction using a computer modelM L Samchukov, J B Cope, R P Harper, et al.
European Journal of Clinical Nutrition|July 7, 2011
A comparison of two screening methods to determine the validity of 24-h food and drink records in children and adolescentsS A Elliott, P S W Davies, S Nambiar, et al.
European Review for Medical and Pharmacological Sciences|March 6, 2023
Emotional intelligence and academic performance among medical students - a correlational studyT Alvi, R L Nadakuditi, T H Alotaibi, et al.
Current Opinion in Pediatrics|August 16, 2020
Prevention of adverse drug effects: a pharmacogenomic approachErika N Scott, Jafar S Hasbullah, Bruce C Carleton, et al.
Sexually Transmitted Infections|July 21, 2001
Protease inhibitor related type III hyperlipoproteinaemia is common and not associated with apolipoprotein-E E2/E2 phenotypeM Shahmanesh, H Jaleel, Y DeSilva, et al.
Pageof 191